The 20 Best POEMS Syndrome Doctors in Maryland, US

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration.

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Transplant.

As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation. Patient appointments: 410-955-8893. Dr. Jain is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenomegaly, Bone Marrow Transplant, and Splenectomy.

Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Sandra J. Ginsberg is a medical oncologist affiliated with Sibley Memorial Hospital, Georgetown University Hospital and George Washington University Hospital. She practices out of Drs. Adelson and Ginsberg in Washington, D.C. Dr. Ginsberg earned her medical degree at the University of Chicago Pritzker School of Medicine. She completed a residency in internal medicine at the State University of New York Health Science Center at Syracuse, followed by a fellowship in medical oncology at the University of Washington and a fellowship in hematology at the State University of New York Health Science Center at Syracuse. Dr. Ginsberg is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Vitamin D Deficiency, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia.

Richard Schraeder is a Hematologist and an Oncologist in Towson, Maryland. Dr. Schraeder is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Retroperitoneal Liposarcoma. Dr. Schraeder is currently accepting new patients.

Syed Nasir is an Oncologist in Towson, Maryland. Dr. Nasir is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast. Dr. Nasir is currently accepting new patients.

Justin Kucinski is a primary care provider, practicing in Internal Medicine in Berlin, Maryland. Dr. Kucinski is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Dehydration, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Iron Deficiency Anemia, and Bone Marrow Aspiration.

Justinian Ngaiza is an Oncologist in Salisbury, Maryland. Dr. Ngaiza is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Von Willebrand Disease (VWD), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Mei Tang is a Hematologist in Towson, Maryland. Dr. Tang is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Myelodysplastic Syndrome (MDS), and Large-Cell Immunoblastic Lymphoma.

Peter Graze is an Oncologist in Annapolis, Maryland. Dr. Graze is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC).

Flavio Kruter is an Oncologist in Westminster, Maryland. Dr. Kruter is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Hemangioma Thrombocytopenia Syndrome, Essential Thrombocythemia, and Bone Marrow Aspiration.

Kashif Ali is an Oncologist in Silver Spring, Maryland. Dr. Ali is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Iron Deficiency Anemia, Chronic Familial Neutropenia, Agranulocytosis, and Childhood Iron Deficiency Anemia.

Danica Novacic is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Novacic is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Splenomegaly, Magnesium Deficiency, Renal Hypomagnesemia Type 2, and Calciphylaxis.

Alida Espinoza is an Oncologist in Silver Spring, Maryland. Dr. Espinoza is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.

Richard Huslig is a Hematologist and an Oncologist in Lutherville Timonium, Maryland. Dr. Huslig is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, Lung Cancer, and Colorectal Cancer.

Cheryl Aylesworth is an Oncologist in Rockville, Maryland. Dr. Aylesworth is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Ovarian Cancer.

Mohammad Meelu is a Hematologist in Waldorf, Maryland. Dr. Meelu is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Blood Clots, Vitamin B12 Deficiency, Pleuropulmonary Blastoma, and Subacute Combined Degeneration.

Nouman Asif is an Oncologist in Frederick, Maryland. Dr. Asif is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Anemia, and Thrombocytopenia.